Potential biomarker for early risk assessment of prostate cancer - Markushin, Y.; Gaikwad, N.; Zhang, H.; Kapke, P.; Rogan, E.G.; Cavalieri, E.L.; Trock, B.J.; Pavlovich, C.; Jankowiak, R. (The Prostate, 2006)
Keywords: Antibodies, Monoclonal; Biological and medical sciences; biomarkers; Biomarkers, Tumor - urine; DNA adducts; DNA Adducts - chemistry; DNA Adducts - immunology; DNA Adducts - urine; Early Diagnosis; Electrophoresis, Capillary; Estradiol - analogs & derivatives; Estradiol - chemistry; Estradiol - immunology; Estradiol - urine; estrogens; Estrogens, Catechol; Gynecology. Andrology. Obstetrics; Humans; Hydroxyestrones - chemistry; Hydroxyestrones - immunology; Hydroxyestrones - urine; Male; Male genital diseases; Medical sciences; Nephrology. Urinary tract diseases; prostate cancer; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - epidemiology; Prostatic Neoplasms - urine; risk assessment; Risk Factors; Tumors; Tumors of the urinary system; Urinary tract. Prostate gland; Andrology; risk assessment; Nephrology; Urinary system disease; Prostate disease; Gynecology; biomarkers; Estrogen; Biological marker; estrogens; Biological indicator; Malignant tumor; Epidemiology; Ovarian hormone; DNA; Risk factor; Early; DNA adducts; Sex steroid hormone; Male genital diseases; Prostate cancer; Molecular adduct